Susan S. Jick, DSc
Adjunct Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Boston University
DSc, Boston University

Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.

Boston University
Evans Center for Interdisciplinary Biomedical Research

Iodinated contrast agents and risk of hypothyroidism in young children in the United States
04/29/2016 - 10/31/2017 (PI)
Bayer AG

Maternal depression and antidepressant use during pregnancy and risk of childhood autism spectrum disorders in offspring
09/01/2015 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development

A Postmarketing Surveillance Study of Otezla
11/01/2015 - 07/21/2017 (PI)
Celgene Corporation

Study of patients with rare disease
05/27/2016 - 05/26/2017 (Subcontract PI)
EpiSource, LLC Genzyme Corporation

Longitudinal Study of Morbidity and Mortality in Primary Vasculitis
03/01/2015 - 02/28/2017 (PI)
Vasculitis Foundation

Prevalence of hypercalcemia of malignancy (HCM) among cancer patients (C14-018)
02/14/2014 - 12/31/2016 (PI)
Amgen, Inc.

Persistent Side-Effects of 5-Alpha-Reductase Inhibitor Treatment
09/01/2014 - 07/31/2016 (Subcontract PI)
New England Research Institutes NIH NIDDK

Incidence, prevalence and treatment patterns of pediatric pulmonary hypertension in the US
09/21/2015 - 03/31/2016 (PI)
Bayer AG

A study to estimate the prevalence of diabetic nephropathy in a pediatric United States population
12/19/2014 - 06/30/2015 (PI)
Bayer AG

Epidemiology of Giant Cell Tumor of the Bone in the UK - Phase II (C13-135)
12/01/2013 - 04/30/2015 (PI)
Amgen, Inc.

Showing 10 of 14 results. Show All Results


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Troelsen FS, Farkas DK, Ording AG, Erichsen R, Jick S, Sørensen HT. Prevalence of Colorectal Neoplasms and Mortality in New Users of Low-Dose Aspirin With Lower Gastrointestinal Bleeding. Am J Ther. 2021 Jan-Feb 01; 28(1):e19-e29.View Related Profiles. PMID: 31356342
  2. Marxer CA, Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study. J Invest Dermatol. 2020 Nov 19. PMID: 33221338
  3. Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risks of major cardiac events among patients with psoriatic arthritis treated with apremilast, biologics, DMARDs or corticosteroids. Rheumatology (Oxford). 2020 Nov 07. PMID: 33159794
  4. Charlier S, Vavanikunnel J, Becker C, Jick SS, Meier C, Meier CR. Antidiabetic treatment, level of glycemic control, and risk of fracture in diabetes type 2: A nested case-control study. J Clin Endocrinol Metab. 2020 Nov 03. PMID: 33141149
  5. Persson R, Vasilakis-Scaramozza C, Hagberg KW, Sponholtz T, Williams T, Myles P, Jick SS. CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities. Pharmacoepidemiol Drug Saf. 2020 11; 29(11):1456-1464.View Related Profiles. PMID: 32986901
  6. Leuppi-Taegtmeyer AB, Reinau D, Yilmaz S, Rüegg S, Krähenbühl S, Jick SS, Leuppi JD, Meier CR. Antiseizure drugs and risk of developing smoking-related chronic obstructive pulmonary disease or lung cancer: A population-based case-control study. Br J Clin Pharmacol. 2020 Aug 01. PMID: 32738070
  7. Persson R, Lee S, Yood MU, Wagner MR, Minton N, Niemcryk S, Lindholm A, Evans AM, Jick S. Incident depression in patients diagnosed with multiple sclerosis: a multi-database study. Eur J Neurol. 2020 08; 27(8):1556-1560.View Related Profiles. PMID: 32397001
  8. Qian Y, Jick S. Proton-pump Inhibitor Use and Myocardial Infarction: A Nested Case-Control Study in the UK Clinical Practice Research Datalink. Epidemiology. 2020 05; 31(3):423-431. PMID: 31809341
  9. Jick SS, Hagberg KW, Persson R, Vasilakis-Scaramozza C, Williams T, Crellin E, Myles P. Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2020 09; 29(9):1134-1140. PMID: 32222005
  10. Persson R, Hagberg KW, Qian Y, Vasilakis-Scaramozza C, Jick S. The risk of myocardial infarction, stroke, and revascularization among patients with psoriasis treated with apremilast compared with biologics and disease-modifying antirheumatic drugs: A cohort study in the US MarketScan database. J Am Acad Dermatol. 2020 Jul; 83(1):271-274. PMID: 32222448
Showing 10 of 301 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 301 publications over 36 distinct years, with a maximum of 27 publications in 2016


Contact for Mentoring:

11 Muzzey St
Lexington MA 02421
Google Map

Jick's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department